About the Trial
We are seeking volunteers for a 16-week clinical trial examining 5-MeO-DMT with psychological support for Treatment Resistant Depression. 5-MeO-DMT is a psychedelic compound with unique properties that are currently being investigated.
This trial aims to investigate different dosages of 5-MeO-DMT to determine which works best. Participants will undergo a single 5-MeO-DMT dosing session, accompanied by six psychological support sessions (three before and three after dosing).
While there is no guarantee of resolving anyone’s depression, your participation will contribute to advancing research on this treatment and provide you with an opportunity for personal insight.
Benefits include:
- Access to a novel treatment option
- Contribution to scientific research on Treatment-Resistant Depression
- Reimbursement for travel-related expenses
Risks include:
- 5-MeO-DMT is an experimental drug where risks are not fully known. In previous research it has been shown to be well tolerated and safe.
Study participants will be expected to:
- Abstain from illicit drugs for the duration of the trial.
- Attend all study visits (14 visits over 16 weeks).
- Inform their existing general practitioner about study participation.
Study participants must:
- Have treatment resistant depression.
- Be between 18 and 75 years old.
- Be willing to discontinue current antidepressants during the trial.
- Live in the Portland, OR area.
- (More detailed criteria can be found on the ClinicalTrials.gov listing)
Learn More About This Trial on ClinicalTrials.Gov
How to participate
If you are interested in being screened, please click on the button below to take the pre-screening survey. This should take less than 5 minutes.
If you have questions, please email us at TRDStudy@portlandpsychotherapy.com.
About the Sponsor
Beckley Psytech Ltd is a small pharmaceutical company dedicated to helping people suffering from neurological & psychiatric disorders. They are developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.
They believe psychedelic medicines could be transformative in difficult to treat psychiatric disorders. They were born out of the Beckley Foundation, one of the earliest nonprofits to fund research on psychedelics.